Key Takeaways
- White House issued warnings on Tylenol for pregnant patients, promoted leukavorin for autism.
- Trump administration proposed a $100,000 application fee for new H-1B visas.
- Organ transplantation industry faces scrutiny after a patient was nearly harvested prematurely.
- Briefs: Jimmy Kimmel's return, Nvidia-OpenAI $100B deal, Build-A-Bear stock surge.
Deep Dive
- The White House announced a warning against recommending Tylenol (acetaminophen) for pregnant patients, linking it to rising autism rates.
- Administration officials cited recent research suggesting a potential association, though scientists emphasize a lack of proven causal link and its established safety profile.
- Tylenol's maker, Kenview, disputed the administration's claims, expressing concern about potential health risks and confusion for expectant mothers.
- The FDA is set to change the label of leukavorin to treat autism, specifically for cerebral folate deficiency, based on emerging evidence from small studies.
- The Trump administration announced a proposed $100,000 application fee for new H-1B visas, a significant increase from the current $2,000-$5,000 range.
- Andrew Craigbaum of Bloomberg Law clarified that the $100,000 would be a one-off charge for new applicants, not annual, and would take effect the following year.
- Despite an annual cap of 85,000 H-1B visas, recipients have an outsized impact on the U.S. economy, representing a primary pathway for international talent.
- Howard Luttnick indicated the administration's rationale is to encourage companies to train domestic graduates rather than rely on foreign workers.
- A KFF Health News report highlights critical issues in the organ transplantation industry.
- One case detailed a 22-year-old patient, Larry Black Jr., who was nearly prepped for organ harvesting despite showing signs of potential recovery.
- The incident, investigated by KFF Health News, underscores concerns about medical protocols and the precise definition of brain death.
- Jimmy Kimmel is returning to his late-night show after a suspension, though some ABC affiliates will preempt it.
- NVIDIA announced a significant $100 billion deal with OpenAI to supply chips for AI development.
- Build-A-Bear's stock has surged over 2,000% in five years, driven by its unique in-store experience and adult collector market.